- Revolutionizing Cell Immunotherapies with Serum Free T Cell Media
Revolutionizing Cell Immunotherapies with Serum Free T Cell Media
Published on 2 September 2021
Eliminate Serum & Blood-Derived Components from Your Immunotherapy Applications
CAR T Cell Therapy Shows Promise for Treating Several Applications
Pharma Tech Outlook interviewed our CEO Scott Deeter, who shares how InVitria is revolutionizing T cell immunotherapies.
InVitria offers the experience and expertise to help you supplement your media of choice with its full line of animal-free, serum-free, recombinant individual cell-culture components. If you would like to read further about InVitria’s animal-, human-, and blood-free T Cell Media, check out our immunotherapy applications page to see how our proven performance and consistency could transform your application.Immunotherapy
Download PDF Here